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1. Introduction 
Cyclic AMP-independent casein kinases are present 
in a variety of mammalian tissues, including rabbit 
muscle [l-3] and reticulocytes [4], pig leucocytes 
[5], bovine adrenal cortex [6], rat liver nuclei [7] and 
cytosol [8,9]. Each one of these tissues contains two 
types of casein kinases which can be tentatively clas- 
sified according to their molecular weights: type I has 
M, 34 000-42 000; type II has Mr 123 000-l 90 000. 
These two types of enzymes are also different in their 
kinetic properties. An important characteristic of 
both types of enzymes from rabbit muscle, pig leuco- 
cytes and rat liver cytosol is that they phosphorylate 
and inactivate I-form glycogen synthase in a cyclic 
AMP- and Ca*+-independent manner. However, the 
effects promoted by the type I enzymes are greater 
than those promoted by the type II. 
Whether or not these kinases are regulated by 
intracellular modulators is still unknown. In [ lo,1 l] 
a heat-stable protein inhibitor of the G-type (type II) 
casein kinase has been described in adrenal cortex, 
which was inactive on the A-type (type I) enzyme 
from the same tissue. The presence of a protein inhib- 
itor has also been reported in rat liver nuclei [ 121. 
The latter inhibits only the casein kinases of nuclear 
origin, being inactive on the cytosolic enzymes. 
Here we report a heat-labile inhibitor in rat liver 
cytosol, of both cytosolic casein kinase 1 (CK-1 or 
type I) and 2 (CK-2 or type II) from the same tissue. 
The inhibiting effect was not due to ATPase, protein 
phosphatase or protease activity. The possible role 
of this inhibitor in the physiological regulation of the 
cytosolic casein kinases is discussed. 
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2. Methods 
2.1. Protein kinase, protein phosphatase and inhibitor 
assays 
Protein kinase assay was done at 30°C for 10 min 
under the standard assay conditions in [ 11. One unit 
of casein kinase is the amount of enzyme that cata- 
lyzes the transfer of 1 nmol 32P/min from [Y-~‘]ATP 
to casein under these conditions. 
Protein phosphatase was assayed by measuring the 
release of 32Pi from [32P]casein at 30°C in a 50 jJ 
reaction mixture containing 50 mM Tris-HCl (pH 7.5), 
1 mM dithiothreitol, 5% glycerol, 8 mM magnesium 
acetate, 2 mg/ml of [32P]casein and phosphatase. The 
32Pi and the remaining [32P]casein were separated by 
instant thin-layer chromatography as in [ 131. One 
unit of casein phophatase is the amount of enzyme 
required to release 1 nmol 32Pi/min. 
The assay of the inhibitor was based on its ability 
to inhibit the casein kinase activity under conditions 
similar to those described as standard for protein 
kinase assay, except for the presence of the indicated 
amount of inhibitor. The data are indicated either as 
the percentage of inhibition observed when using 
1 .O unit/ml of purified casein kinase, or as IPSO, 
which is the amount of inhibitor protein &g/50 ~1 
assay) necessary to promote a 50% inhibition of the 
casein kinase activity. 
2.2. Preparation of casein kinases 1 and 2 (CK-I and 
CK-2) 
These enzymes were isolated from rat liver cytosol 
by chromatography on phosphocellulose and casein- 
Sepharose 4B as in [9]. The specific activities of the 
purified enzymes were 200 and 60 units/mg protein 
for CK-1 and CK-2, respectively. 
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2.3. Miscellaneous 
Histone II A was bound to activated Sepharose 4B 
according [ 141. [y-32P]ATP was prepared as in [ 151. 
[32P] Casein was prepared using casein (Merck), [T-~*P]- 
ATP and purified CK-2. Protein was measured as 
in [16]. 
3. Results 
3 .l . Evidence of inhibitory activity in crude extracts 
The cyclic AMP-independent casein kinase activity 
present in crude extracts from rat liver cytosol, 
obtained as in [9], varied non-linearly with respect to 
dilution. As can be observed in fig.1, the specific 
activity decreased as the amount of extract used in 
the assay was increased. The presence of 100 mM KF 
did not abolish this effect, although the activities 
were greater than those determined in its absence. 
Furthermore, when 5 ~1 crude extract were included 
in a 50 ~1 casein kinase standard assay mixture con- 
taning 1.3 units/ml of either purified CK-1 or CK-2, 
- 0 01 Q2 
ml of extract/ml of assay 
Fig.1. Effect of dilution on casein kinase activity in crude 
extracts. Casein kinase activity was assayed both in the 
absence (0) and in the presence of 100 mM KF (0) using the 
indicated amount of crude extract. 
the activities of the kinases decreased by 88% and 
85%, respectively. In fact the degree of inhibition 
would be even greater if the contribution by the 
crude extract to the total casein kinase activity in the 
assay (0.08 units/ml) was considered. The presence of 
neither 0.25 mM phenylmethylsulphonyl fluoride, 
0.5 mg/ml soybean trypsin inhibitor nor 100 mM KF 
prevented the inactivation. However, the inhibitory 
activity disappeared when the extract was heated in 
boiling water for 3 min. These results indicated the 
existence of some heat-labile inhibitor of the kinases 
in the extracts, which was probably different from 
the phosphocasein phosphatases and proteases. 
3.2. Partial purification of the inhibitor 
The initial steps were similar to those reported for 
the purification of the casein kinases [9]. The flow- 
through fraction from the first phosphocellulose col- 
umn was used in order to purify the inhibitor. Of this 
preparation 10 ml was applied to a 1.5 X 8 cm his- 
tone-Sepharose 4B column equilibrated with 50 mM 
Tris-HCl buffer (pH 7.5) containing 1 mM dithio- 
threitol, 0.1 mM phenylmethylsulphonyl fluoride and 
5% glycerol (buffer A), then the column was washed 
with 100 ml of the same buffer. 
The inhibitor was not adsorbed to the column 
under these conditions whereas most of the phos- 
phatase and histone kinase activities were retained 
(not shown). Fractions containing the inhibitor were 
pooled and applied to a 1.5 X 12 cm DEAF-cellulose 
column equilibrated with buffer A which was washed 
with 100 ml same buffer. The inhibitor was recovered 
in the flowthrough fraction and then it was concen- 
trated by dialysis against buffer A containing 50% 
glycerol followed by dialysis against buffer A. It is 
difficult to quantify the extent of purification and 
recovery by this procedure because of the presence in 
the extracts of the inhibitor and also casein kinases 
and phosphatases not separable from the inhibitor 
until the phosphocellulose and histone-Sepharose 4B 
steps were performed (table 1). Furthermore the 
degree of inhibition was not linearly related to the 
amount of inhibitor present in the assay mixture, 
making it more difficult to evaluate its content in the 
different steps of the purification (see below). 
3.3. Characteristics of the inhibitor 
When incubated with ATP under conditions similar 
to those reported as standard for protein kinase assay 
except for the absence of casein and casein kinase the 
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Table 1 
Partial purification of the inhibitor 
Fraction Total Casein Casein ID,, (@g/assay) 
protein kinase phosphatase 
(mg) (units/mg) (unitslmg) CK-1 CK-2 
First peak 
phosphocellulose 157.5 0.013 0.025 _ _ 
Histone- 
Sepharose 66.5 0.002 0.002 58 47 
DEAE-cellulose 
(concentrated) 15.1 0 0 35 27 
Assay conditions and definition of units are in section 2.1 
inhibitor did not promote any release of ADP as 
determined chromatographically according to [17], 
even in the presence of 1 .O mM ATP. Furthermore 
the inhibitor did not inhibit hexokinase (not shown). 
To test whether or not the inhibition was due to 
proteolytic degradation of the casein kinases by the 
inhibitor, a 0.5 ml reaction mixture containing 1 .O 
unit/ml of either CK-1 or CK-2, and 0.5 mg/ml of 
inhibitor was incubated at 30°C for 10 min. Each 
incubation mixture was then applied to a 0.3 ml 
phosphocellulose column equilibrated with buffer A. 
After washing the columns with 1 ml buffer A and 
1 ml buffer A containing 0.3 M KCl the casein kinases 
were eluted by applying 1 ml buffer A containing 2 M 
KCl. Virtually all the casein kinase activity (95-98%) 
was recovered when either CK-1 or CK-2 were used 
indicating that the inhibition was easily reversible. 
16 A 
Fig.2. Time-independence of the effect of the inhibitor. A 
0.2 ml reaction mixture similar to that standard for protein 
kinase assay, containing 1 .O unit/ml of either CK-1 (A) or 
CK-2 (B) was incubated at 30°C either in the absence (0) or 
presence (0) of 0.6 mg inhibitor/ml. At indicated times 20 til 
samples were removed for the determination of the azP 
incorporated. 
The effect of the inhibitor was determined at dif- 
ferent times of incubation at 30°C (fig.%) and it was 
observed that the extent of inhibition remained con- 
stant for 30 min when either purified CK-1 or CK-2 
were used. 
The extent of inhibition promoted depended on 
the amount of inhibitor added (fig.3). However, there 
was not a linear but a hyperbolic relation between 
both parameters when either purified CK-1 or CK-2 
were used. One can also observe that both kinases 
were inhibited to a similar extent by a fixed amount 
of inhibitor. 
tJg inhibitor/assay 
Fig.3. Degree of inhibition as a function of inhibitor concen- 
tration. Inhibitory activity was assayed in the presence of 
increasing amounts of inhibitor using either purified CK-1 (o) 
or CK-2 (0). 
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4. Discussion 
An inhibitor of the cyclic AMP-independent casein 
kinases has been shown in rat liver cytosol. The inhib- 
itory activity was not due to either destruction of the 
kinases or interference with the kinase assay by 
ATPase or phosphatase activity as indicated by: 
(i) The easy reversibility of the enzyme-inhibitor 
complex; 
(ii) The invariance of the degree of inhibition with 
time; 
(iii) The ineffectiveness of the inhibitor on hexo- 
kinase ; 
(iv) The lack of ATPase or casein phosphatase activ- 
ity as determined by direct assay. 
Furthermore, the degree of inhibition varied according 
to concentration in a way similar to the interaction 
between an enzyme and its inhibitor. 
Interest has been shown in the cyclic AMP-indepen- 
dent protein kinases due to their putative role in the 
regulation of glucose and lipid metabolism. Among 
these kinases those denominated as casein kinases 1 
and 2 (type I and II) from various sources, including 
rat liver cytosol [8,9], have been shown to phospho- 
rylate and inactivate I-form glycogen synthase. How- 
ever, there is little information concerning the regula- 
tion of these kinases, since they are neither inhibited 
by the cyclic AMP-dependent protein kinase inhibitor 
protein nor stimulated by Ca2+, cahnodulin or a com- 
bination of the two. The presence of a natural inhibi- 
‘tor reported herein would provide a possible regulatory 
mechanism for these enzymes in rat liver. 
Other non-dialyzable inhibitors of casein kinases 
have been described in bovine adrenal cortex cytosol 
[lo,1 l] and rat liver nuclei [ 121. However, the first 
inhibitor differs from ours in that it is heat-stable and 
inhibits only one of the casein kinases, the so-called 
G-type (type II, probably). The second one is also 
different from ours, since it is inactive on the casein 
kinases from rat liver cytosol. 
Evaluation of the physiological inhibitory poten- 
tial of the inhibitor would be difficult because of the 
presence in crude extracts of various kinases and 
phosphatases able to act on casein and the non- 
linearity of the concentration dependence effect of 
the inhibitor. However, some information about the 
degree of the inhibition of the casein kinases ‘in vivo’ 
can be obtained considering that: 
(i) The casein kinase activity present in the crude 
extracts increased by 1 O-fold with dilution; 
(ii) An amount of undiluted crude extract which 
accounted for 0.08 units of casein kinase/ml 
assay mixture inhibited by X5% a 16-fold 
greater amount of added casein kinase. 
Thus the inhibitor may be of importance in the regu- 
lation of the cytosolic casein kinases in rat liver. 
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